# DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold

> **NCT03074305** · NA · WITHDRAWN · sponsor: **Samsung Medical Center**

## Conditions studied

- Coronary Artery Disease
- Coronary Restenosis

## Interventions

- **DEVICE:** PCI for in-bioresorbable scaffold stenosis

## Key facts

- **NCT ID:** NCT03074305
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-03-08
- **Primary completion:** 2017-12-30
- **Final completion:** 2018-01-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** cannot use bioabsorbable scaffold
- **Last updated:** 2024-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03074305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03074305, "DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03074305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*